Back
Viridian Therapeutics Vs. Innodata Industry Stock Comparison
Sell
41
VRDN
Viridian Therapeutics
Last Price:
$20.07
Seasonality Move:
1.18%
Buy
60
INOD
Innodata
Last Price:
$43.78
Seasonality Move:
3.52%
Sell
41
Viridian Therapeutics (VRDN)
is a Sell
Is Viridian Therapeutics a Buy, Sell or Hold?
-
The current Viridian Therapeutics [VRDN] share price is $20.07. The Score for VRDN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
VRDN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRDN Stock Price Chart
What is Viridian Therapeutics's stock price today?
-
The Viridian Therapeutics share price today is $20.07The current trend is relatively stagnant and VRDN is experiencing slight buying pressure.
VRDN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 50.63 | Buy |
Chaikin Money Flow: | 71365 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.78 - 20.56) | Buy |
Bollinger Bands (100): | (17.17 - 23.49) | Sell |
INOD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.54 | Buy |
Relative Strength Index (14 RSI): | 56.3 | Buy |
Chaikin Money Flow: | -1088316 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.52 - 44.56) | Buy |
Bollinger Bands (100): | (14.61 - 38.97) | Buy |
VRDN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.67 | Buy |
20-day SMA: | 19.48 | Buy |
50-day SMA: | 20.96 | Sell |
200-day SMA: | 17.35 | Buy |
8-day EMA: | 19.75 | Buy |
20-day EMA: | 19.8 | Buy |
50-day EMA: | 20.32 | Sell |
200-day EMA: | 18.94 | Buy |
INOD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.98 | Buy |
20-day SMA: | 40.66 | Buy |
50-day SMA: | 37.14 | Buy |
200-day SMA: | 19.52 | Buy |
8-day EMA: | 42.39 | Buy |
20-day EMA: | 41.22 | Buy |
50-day EMA: | 36.6 | Buy |
200-day EMA: | 23.13 | Buy |
Viridian Therapeutics Earnings Growth & VRDN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $0.15 per share.
Innodata Earnings Growth & INOD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.41 per share.
Viridian Therapeutics Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Innodata Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |